About this research group
This research group focuses on the extracellular matrix under physiological and pathological conditions. The extracellular matrix is studied to rationally design and implement acellular biodegradable biomaterials that promote the patient’s own regenerative capacity.
read moreAbout this research group
This research group focuses on the extracellular matrix under physiological and pathological conditions. The extracellular matrix is studied to rationally design and implement acellular biodegradable biomaterials that promote the patient’s own regenerative capacity. In addition, a more fundamental investigation in changes in the extracellular matrix contributes to the understanding of the importance of the extracellular matrix in regenerative wound healing.
Aims
The research group has two focus areas related to soft tissue regeneration:
Biomaterials
With respect to biomaterials, an in vivo regenerative approach is envisoned, in which the biomaterials form the scaffold that instruct cells to regenerate the original tissue. This goal is studied by structuring the scaffold (physical cues) and applying (bio)molecules that stimulate cellular differentiation (biological cues) or applying specific release systems. In a natural situation, it is the extracellular matrix that functions as this scaffold. It is therefore a rational choice to use (molecules from) the extracellular matrix as biomaterials in regenerative medicine. Research on soft tissue regeneration encompasses e.g. skin, skeletal muscle and urogenital tissues (like bladder, urethra and ureters). Congenital anomalies that need closure of a defect are a particular topic of interest, e.g. congenital diaphragmatic hernia and spina bifida, as in the growing child restoration of functional tissue that can grow with the child is of vital importance.
Glycosaminoglycans
With respect to glycosaminoglycans, the sugar moiety of proteoglycans, our research studies their role in health and disease, e.g. ovarian cancer, Alzheimer’s & Parkinson’s Disease. The lab’s single chain variable fragment antibodies against glycosaminoglycan epitopes provide a unique tool for these studies.
Discoveries
Our group made several discoveries and our research forms the basis of various projects.
Lees meer